(LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of Calculation of (Loss) Per Share

Calculation of (loss) per share:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2023		2022		2023		2022
Net (loss)	$	(7,279)	$	(93,520)	$	(74,857)	$	(380,195)
Weighted-average common shares outstanding	83,336		81,996		82,996		81,842
(Loss) per share, basic	$	(0.09)	$	(1.14)	$	(0.90)	$	(4.65)

Net (loss)	$	(7,279)	$	(93,520)	$	(74,857)	$	(380,195)







Weighted-average common shares outstanding, assuming dilution (1) (2) (3)	83,336		81,996		82,996		81,842
(Loss) per share, diluted	$	(0.09)	$	(1.14)	$	(0.90)	$	(4.65)

Outstanding anti-dilutive stock options and RSUs (4)	2,255		3,019		1,652		3,589

(1) All dilutive securities are excluded in periods of loss as their inclusion would be anti-dilutive.

(2) The shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period. If the outstanding conversion options were fully exercised, the Company would issue approximately 3.7 million shares as of September 30, 2023.

(3) The Company’s Capped Call Transactions represent the equivalent of approximately 3.7 million shares of the Company’s common stock (representing the number of shares for which the Notes are convertible) as of September 30, 2023. The Capped Call Transactions are expected to reduce common stock dilution and/or offset any potential cash payments the Company must make, other than for principal and interest, upon conversion of the Notes, with such reduction and/or offset subject to a cap of $196.44. The Capped Call Transactions are excluded from weighted-average common shares outstanding, assuming dilution, in all periods as their effect would be anti-dilutive.

(4) Outstanding stock options and RSUs that were anti-dilutive under the treasury stock method in the period were excluded from the computation of diluted (loss) per share. These awards may be dilutive in the future.